InsiderTrades.com logo
27 U.S. Cities Where Stocks Yield 26% a Year
From Investing Daily   |   Ad
What’s the highest-yielding stock you’ve ever owned?

The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Get in on the action here.

RANI Insider Trading

Insider Ownership Percentage: 50.02%
Insider Buying (Last 12 Months): $1,553,592.42
Insider Selling (Last 12 Months): $853,881.28

Rani Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Rani Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Rani Therapeutics Share Price & Price History

Current Price: $4.28
Price Change: ▲ Price Increase of +0.2 (4.90%)
As of 06/1/2023 06:11 PM ET

This chart shows the closing price history over time for RANI up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Graphite versus Lithium - What Investors Should Know
From Edge On The Street   |   Ad
Over 18 million EVs will be cruising U.S roads by 2030. And every one million EVs manufactured will require 82,000 tons of the metal graphite for their batteries. That's a total of 1,476,000 tons of graphite! Graphite is actually the largest component of EV batteries - NOT lithium. Experts warn of a massive graphite shortfall, especially since North America currently has no operating graphite mines.
See why graphite could be the "new lithium"

Rani Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/11/2023South Cone Investments LimitedMajor ShareholderBuy2,610$3.87$10,100.706,863,744View SEC Filing Icon  
5/8/2023South Cone Investments LimitedMajor ShareholderBuy4,420$4.46$19,713.206,861,134View SEC Filing Icon  
5/3/2023South Cone Investments LimitedMajor ShareholderBuy2,040$4.81$9,812.406,856,714View SEC Filing Icon  
4/28/2023South Cone Investments LimitedMajor ShareholderBuy2,173$4.71$10,234.836,854,674View SEC Filing Icon  
4/24/2023South Cone Investments LimitedMajor ShareholderBuy4,280$4.67$19,987.606,848,078View SEC Filing Icon  
4/20/2023South Cone Investments LimitedMajor ShareholderBuy1,850$5.32$9,842.006,839,698View SEC Filing Icon  
4/18/2023South Cone Investments LimitedMajor ShareholderBuy1,850$5.37$9,934.506,837,848View SEC Filing Icon  
4/14/2023South Cone Investments LimitedMajor ShareholderBuy1,901$5.27$10,018.276,835,998View SEC Filing Icon  
4/12/2023South Cone Investments LimitedMajor ShareholderBuy3,577$5.48$19,601.966,833,207View SEC Filing Icon  
4/10/2023South Cone Investments LimitedMajor ShareholderBuy1,923$5.07$9,749.616,827,865View SEC Filing Icon  
4/5/2023South Cone Investments LimitedMajor ShareholderBuy7,280$5.49$39,967.206,818,391View SEC Filing Icon  
4/3/2023South Cone Investments LimitedMajor ShareholderBuy3,587$5.23$18,760.016,806,695View SEC Filing Icon  
3/30/2023South Cone Investments LimitedMajor ShareholderBuy12,230$4.79$58,581.706,802,357View SEC Filing Icon  
3/28/2023South Cone Investments LimitedMajor ShareholderBuy3,510$5.49$19,269.906,790,127View SEC Filing Icon  
3/20/2023South Cone Investments LimitedMajor ShareholderBuy532$6.29$3,346.286,783,387View SEC Filing Icon  
3/16/2023South Cone Investments LimitedMajor ShareholderBuy1,325$6.07$8,042.756,779,875View SEC Filing Icon  
3/13/2023South Cone Investments LimitedMajor ShareholderBuy2,463$6.14$15,122.826,778,550View SEC Filing Icon  
3/8/2023South Cone Investments LimitedMajor ShareholderBuy1,702$6.58$11,199.166,772,357View SEC Filing Icon  
3/6/2023South Cone Investments LimitedMajor ShareholderBuy1,100$6.39$7,029.006,770,655View SEC Filing Icon  
3/2/2023South Cone Investments LimitedMajor ShareholderBuy3,900$6.31$24,609.006,769,555View SEC Filing Icon  
2/27/2023South Cone Investments LimitedMajor ShareholderBuy3,541$6.30$22,308.306,764,944View SEC Filing Icon  
2/24/2023South Cone Investments LimitedMajor ShareholderBuy5,451$6.09$33,196.596,761,403View SEC Filing Icon  
2/21/2023South Cone Investments LimitedMajor ShareholderBuy3,080$5.94$18,295.206,754,952View SEC Filing Icon  
2/16/2023South Cone Investments LimitedMajor ShareholderBuy9,500$5.49$52,155.006,743,404View SEC Filing Icon  
2/14/2023South Cone Investments LimitedMajor ShareholderBuy9,250$5.25$48,562.506,723,904View SEC Filing Icon  
12/28/2022South Cone Investments LimitedMajor ShareholderBuy9,157$5.58$51,096.066,697,454View SEC Filing Icon  
12/19/2022South Cone Investments LimitedMajor ShareholderBuy6,900$7.43$51,267.006,688,297View SEC Filing Icon  
12/16/2022South Cone Investments LimitedMajor ShareholderBuy6,400$7.76$49,664.006,681,397View SEC Filing Icon  
12/12/2022South Cone Investments LimitedMajor ShareholderBuy12,500$8.04$100,500.006,646,628View SEC Filing Icon  
12/9/2022South Cone Investments LimitedMajor ShareholderBuy12,345$8.01$98,883.456,634,128View SEC Filing Icon  
12/7/2022South Cone Investments LimitedMajor ShareholderBuy600$7.94$4,764.006,609,588View SEC Filing Icon  
12/5/2022South Cone Investments LimitedMajor ShareholderBuy12,195$7.97$97,194.156,596,488View SEC Filing Icon  
12/2/2022South Cone Investments LimitedMajor ShareholderBuy9,819$8.16$80,123.046,584,293View SEC Filing Icon  
11/30/2022South Cone Investments LimitedMajor ShareholderBuy8,000$7.93$63,440.006,574,272View SEC Filing Icon  
11/28/2022South Cone Investments LimitedMajor ShareholderBuy3,720$7.95$29,574.006,566,272View SEC Filing Icon  
11/25/2022South Cone Investments LimitedMajor ShareholderBuy800$7.84$6,272.006,562,552View SEC Filing Icon  
11/23/2022South Cone Investments LimitedMajor ShareholderBuy3,396$7.84$26,624.646,561,752View SEC Filing Icon  
11/21/2022South Cone Investments LimitedMajor ShareholderBuy3,200$7.87$25,184.006,545,856View SEC Filing Icon  
11/18/2022South Cone Investments LimitedMajor ShareholderBuy13,300$7.49$99,617.006,542,656View SEC Filing Icon  
11/2/2022Cortes Isidoro Alfonso QuirogaMajor ShareholderBuy25,197$6.31$158,993.075,247,786View SEC Filing Icon  
10/31/2022Cortes Isidoro Alfonso QuirogaMajor ShareholderBuy16,523$6.11$100,955.535,218,821View SEC Filing Icon  
8/17/2022Mir A ImranDirectorSell80,252$10.64$853,881.2866,445View SEC Filing Icon  
See Full Table
ChatGPT Is Already "Old School"
From Edge On The Street   |   Ad
As good as ChatGPT is at writing content, it still doesn't understand what it's saying. But a new AI technology breakthrough will understand and process information like a human. One young company is leading the way.
See How This AI Innovation Could Impact Investors

SEC Filings (Institutional Ownership Changes) for Rani Therapeutics (NASDAQ:RANI)

6.43% of Rani Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at RANI by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Rani Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/16/2023Susquehanna International Group LLP70,772$0.37M0.0%N/A0.143%Search for SEC Filing on Google Icon
5/12/2023Renaissance Technologies LLC41,117$0.21M0.0%+7.1%0.083%Search for SEC Filing on Google Icon
5/12/2023Bank of America Corp DE13,451$69K0.0%+250.9%0.027%Search for SEC Filing on Google Icon
5/12/2023HRT Financial LP18,098$93K0.0%N/A0.037%Search for SEC Filing on Google Icon
5/11/2023Icon Wealth Partners LLC12,757$66K0.0%N/A0.026%Search for SEC Filing on Google Icon
5/11/2023Alphabet Inc.448,492$2.31M0.1%-12.1%0.908%Search for SEC Filing on Google Icon
2/15/2023Jane Street Group LLC12,929$76K0.0%N/A0.026%Search for SEC Filing on Google Icon
2/15/2023Millennium Management LLC73,144$0.43M0.0%-17.9%0.148%Search for SEC Filing on Google Icon
2/13/2023Brown Advisory Inc.33,911$0.20M0.0%N/A0.069%Search for SEC Filing on Google Icon
2/13/2023Renaissance Technologies LLC38,400$0.23M0.0%N/A0.078%Search for SEC Filing on Google Icon
2/13/2023Geode Capital Management LLC97,185$0.57M0.0%+2.8%0.197%Search for SEC Filing on Google Icon
2/8/2023Prime Capital Investment Advisors LLC33,502$0.20M0.0%N/A0.068%Search for SEC Filing on Google Icon
11/18/2022TPB Wealth Advisors48,129$0.46M0.2%-33.0%0.098%Search for SEC Filing on Google Icon
11/16/2022Alphabet Inc.714,471$6.85M0.3%N/A1.453%Search for SEC Filing on Google Icon
11/15/2022Jacobs Levy Equity Management Inc.18,712$0.18M0.0%N/A0.038%Search for SEC Filing on Google Icon
11/15/2022Vanguard Group Inc.650,978$6.24M0.0%+95.4%1.324%Search for SEC Filing on Google Icon
11/15/2022BlackRock Inc.202,907$1.94M0.0%-1.9%0.413%Search for SEC Filing on Google Icon
11/3/2022Motco48,129$0.46M0.0%N/A0.098%Search for SEC Filing on Google Icon
10/28/2022Lafayette Investments Inc.19,893$0.19M0.1%N/A0.040%Search for SEC Filing on Google Icon
10/17/2022Canton Hathaway LLC16,200$0.16M0.1%+88.4%0.033%Search for SEC Filing on Google Icon
10/14/2022Iowa State Bank18,862$0.18M0.1%N/A0.038%Search for SEC Filing on Google Icon
8/18/2022Goldman Sachs Group Inc.10,739$0.11M0.0%-60.0%0.022%Search for SEC Filing on Google Icon
8/15/2022Millennium Management LLC111,781$1.16M0.0%+243.7%0.227%Search for SEC Filing on Google Icon
8/8/2022Islay Capital Management LLC9,611$99K0.1%N/A0.020%Search for SEC Filing on Google Icon
8/8/2022Crossvault Capital Management LLC14,285$0.15M0.1%N/A0.029%Search for SEC Filing on Google Icon
7/29/2022Aspireon Wealth Advisors71,811$0.74M0.3%N/A0.146%Search for SEC Filing on Google Icon
7/20/2022Canton Hathaway LLC8,600$89K0.0%N/A0.017%Search for SEC Filing on Google Icon
6/15/2022Lasry Marc62,828$0.85M0.4%N/A0.128%Search for SEC Filing on Google Icon
6/7/2022Bank of America Corp DE3,155$42K0.0%-28.7%0.006%Search for SEC Filing on Google Icon
5/17/2022Lasry Marc62,828$0.85M0.4%N/A0.128%Search for SEC Filing on Google Icon
5/16/2022Goldman Sachs Group Inc.26,820$0.36M0.0%N/A0.055%Search for SEC Filing on Google Icon
5/16/2022State Street Corp26,142$0.35M0.0%+32.7%0.053%Search for SEC Filing on Google Icon
5/16/2022UBS Group AG3,570$48K0.0%-31.2%0.007%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.290,107$3.92M0.0%+1.6%0.590%Search for SEC Filing on Google Icon
5/13/2022United Services Automobile Association481,300$6.50M0.1%N/A0.979%Search for SEC Filing on Google Icon
5/12/2022BlackRock Inc.157,374$2.13M0.0%+37.7%0.320%Search for SEC Filing on Google Icon
5/11/2022JPMorgan Chase & Co.2,329$31K0.0%-44.4%0.005%Search for SEC Filing on Google Icon
5/4/2022Advisor Group Holdings Inc.19,343$0.26M0.0%-8.2%0.039%Search for SEC Filing on Google Icon
2/3/2022Advisor Group Holdings Inc.21,072$0.34M0.0%N/A0.043%Search for SEC Filing on Google Icon
1/6/2022Canton Hathaway LLC5,000$82K0.0%-50.0%0.010%Search for SEC Filing on Google Icon
11/16/2021Squarepoint Ops LLC50,000$0.89M0.0%N/A0.102%Search for SEC Filing on Google Icon
11/15/2021Caas Capital Management LP75,000$1.34M0.0%N/A0.153%Search for SEC Filing on Google Icon
11/10/2021Goldman Sachs Group Inc.60,649$1.08M0.0%N/A0.124%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Rani Therapeutics logo
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed Phase I clinical trial for the treatment of neuroendocrine tumors and acromegaly; RT-105, an anti-TNF-alpha antibody to treat psoriatic arthritis; RT-102, a parathyroid hormone that is in preclinical studies for the treatment of osteoporosis; RT-109, a human growth hormone to treat growth hormone deficiency; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; and RT-106, a basal insulin for the treatment of type 2 diabetes. The company was incorporated in 2012 and is headquartered in San Jose, California.
Read More on Rani Therapeutics

Today's Range

Now: $4.28
Low: $4.01
High: $4.29

50 Day Range

MA: $4.80
Low: $3.92
High: $5.58

52 Week Range

Now: $4.28
Low: $3.65
High: $13.44

Volume

55,657 shs

Average Volume

48,741 shs

Market Capitalization

$211.82 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.33

Who are the company insiders with the largest holdings of Rani Therapeutics?

Rani Therapeutics' top insider shareholders include:
  1. South Cone Investments Limited (Major Shareholder)
  2. Cortes Isidoro Alfonso Quiroga (Major Shareholder)
  3. Mir A Imran (Director)
Learn More about top insider investors at Rani Therapeutics.

Who are the major institutional investors of Rani Therapeutics?

Rani Therapeutics' top institutional investors include:
  1. Alphabet Inc. — 0.91%
  2. Susquehanna International Group LLP — 0.14%
  3. Renaissance Technologies LLC — 0.08%
  4. HRT Financial LP — 0.04%
  5. Bank of America Corp DE — 0.03%
  6. Icon Wealth Partners LLC — 0.03%
Learn More about top institutional investors of Rani Therapeutics stock.

Which major investors are selling Rani Therapeutics stock?

During the last quarter, RANI stock was sold by these institutional investors:
  1. Alphabet Inc.

Which major investors are buying Rani Therapeutics stock?

During the last quarter, RANI stock was bought by institutional investors including:
  1. Susquehanna International Group LLP
  2. HRT Financial LP
  3. Icon Wealth Partners LLC
  4. Bank of America Corp DE
  5. Renaissance Technologies LLC
During the previous year, these company insiders have bought Rani Therapeutics stock:
  1. South Cone Investments Limited (Major Shareholder)
  2. Cortes Isidoro Alfonso Quiroga (Major Shareholder)
Learn More investors buying Rani Therapeutics stock.
The $193 Billion US-China War You Don't Know About
From Edge On The Street   |   Ad
They're fighting for control of lithium – a key ingredient in EVs and clean energy technology. It's arguably the most important commodity of the 21st century. China owns 80% of global supply. But the US plans to grab a massive slice of the lithium market, which is forecasted to quadruple to $193 billion by 2028, according to Fortune Business Insights.
This Is Creating Huge Investment Opportunities